In light of recent news about the breast cancer drug Herceptin, Forum discusses the current advancements and challenges in cancer research, funding, prevention, diagnosis and other treatment options.
Guests:
Barbara Brenner, executive director of Breast Cancer Action
Dr. Edward Romond, principle investigator with Genentech and Associate Professor of Medicine in Hematology and Oncology at the University of Kentucky
Marion Kavanaugh-Lynch, M.D., M.P.H., director of the California Breast Cancer Research Program
Dr. Les Reinlib, program official and director of Breast Cancer and the Environment Research Centers at the National Institute of Environmental Health Sciences
Sponsored